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POTENTIAL PREDICTOR OF NEUROLOGICAL IMPAIRMENT 
Simon B N Thompson, Charlotte Frankham and Philip Bishop 
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Background: Thompson Cortisol Hypothesis proposed yawning correlates with rises in cortisol levels. 
Cortisol is fundamental to immune system regulation. Pathological yawning is a symptom of MS. 
Electro-myographical activity (EMG) in the jaw muscles rises when stretched; and is likely to be 
correlated with yawning, and potentially correlated with cortisol levels in healthy people and in MS. 
Objectives: Investigate possible link between EMG in jaw muscles with rises in saliva cortisol levels 
during yawning. Method: Randomized controlled trial: 11 male and 15 female volunteers aged 18-53 
years exposed to conditions that provoked a yawning response. Saliva samples were collected at start 
and after yawning or at the end of stimuli presentations if the participant failed to yawn, and EMG data 
was collected during rest and yawning phases and is novel. Yawning susceptibility scale, Hospital 
Anxiety and Depression Scale, General Health Questionnaire, demographic, health details were 
collected for yawners and non-yawners, between rest and yawning phases. Exclusion criteria: chronic 
fatigue, diabetes, fibromyalgia, heart condition, high blood pressure, hormone replacement therapy, 
multiple sclerosis, stroke. Results: Significant differences between saliva cortisol samples. Yawners, 
t(11) = -3.115, p = 0.010; F (1, 11) = 13.680  p < 0.025, and non-yawners, t(14) = -2.658, p = 0.019; F 
(1, 14) = 4.758  p = 0.047. Moderate, though not significant, correlation between cortisol change (from 
sample 1 to 2) and EMG score: r (7) = 0.440, p = 0.071. Significant difference in EMG readings 
between yawners and non-yawners, t (7) = -2.959, p = 0.021. Conclusions: Thompson Cortisol 
Hypothesis is supported, and EMG is correlated with yawning and elevated cortisol levels. Longitudinal 
study is planned with MS patients to develop an early diagnostic tool. 
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Introduction
Researchers are largely in agreement on the localisation of the process of yawning in the paraventricular 
nucleus of the hypothalamus and the brainstem. However, agreement is yet to be reached on which neuro-
chemicals are fundamental to the yawning episode, albeit a number of neurotransmitters have been 
identified as being implicated [1]. 
Recently, the Thompson Cortisol Hypothesis [2] has proposed that the incidence of yawning is 
associated with rise in saliva cortisol levels. It suggests that either cortisol is a trigger for the yawn reflex 
or is an artefact that may protect the yawner. It is unclear how this mechanism may work within the 
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known Hypothalamus-Pituitary-Adrenal (HPA) axis and may be connected with hypothalamus 
temperature regulation theories such as those prosed by Gallup [3]. Stress and fatigue are known to cause 
elevations in cortisol, and yawning incidence has been shown to be increased at these times [4 - 7]. 
Cortisol is a fundamental component of the stress response and immune system regulation and 
consequently is sensitive to the physiological impact of neurological disorders such as Multiple Sclerosis 
(MS), an inflammatory disease of the central nervous system. Some evidence suggests that excessive and 
pathological yawning is a symptom of MS.  
There is evidence for a potential relationship between yawning and cortisol in MS. Empirical 
evidence for excessive yawning in MS is limited though there is some indication of an association. 
Despite the absence of irrefutable evidence, yawning and MS, cortisol dysregulation and its association 
with stress, depression, fatigue and dysfunctional thermoregulation and the complexity of the interactions 
between these factors, indicates cortisol and yawning is tied in a certain relationship. The establishment of 
a connection between cortisol and yawning may shed further light on MS, and on the function of yawning 
in other neurological disorders. 
Cortisol is often described as the stress hormone. The amygdala detects situations involving 
uncertainty or fear, sending messages to the hypothalamus. Increased stimulation of the hypothalamic-
pituitary-adrenal axis (HPA) by physiological or psychological stressors stimulates an increase in 
production of cortisol from the adrenal gland [8]. The HPA axis is the regulatory neuro-endocrine 
mechanism connecting the central nervous system (CNS) with the hormonal and immune systems and 
maintains homeostasis by facilitating the body’s adaptation to stress.  
Physiological or psychological stressors prompt the secretion of corticotropin-releasing hormone 
(CRH) from the paraventricular nucleus (PVN) of the hypothalamus [9]. CRH triggers the pituitary gland 
to release adrenocorticotropic hormone (ACTH), the secretion of which is also influenced by the 
suprachiasmatic nucleus in the hypothalamus [10]. Stimulation of the adrenal cortex by ACTH induces 
the release of glucocorticoids such as cortisol [11]. 
An important homeostatic role of the hypothalamus is thermoregulation. Temperature is monitored 
by thermo-receptors located in the hypothalamus, which measure the temperature of blood passing 
through the brain to establish the core temperature of the body, and skin receptors track the ambient 
temperature. Deviations in core temperature are detected by the hypothalamus and, taking into account 
the external temperature, the autonomic nervous system (ANS) responds to correct the discrepancy 
through the involuntary mechanisms of conduction, convection, radiation and evaporation.  
Excessive heat prompts sweating and vaso-dilation to promote heat loss and reduce core body 
temperature. Fall in temperature induces shivering and an increase in metabolic rate in an attempt to 
minimise further heat loss and promote warming.  
Physiological adjustments are made constantly by the hypothalamus, and combine with voluntary 
changes in our behaviour, such as fanning when hot, or adding layers of clothing when cold, to maintain 
the body at its optimum temperature of 36.5-37.5˚C when at rest.  
Attempts to understand the significance of yawning have challenged and eluded philosophers and 
scientists alike for centuries, and theories referring to yawning as a mechanism essential to maintenance 
of optimal oxygen levels has been contended for over 200 years [12].  
Most people are aware of increased yawning when fatigued and there is evidence to suggest that 
yawning follows a circadian rhythm correlating with individual preferences for early waking or late 
retiring. Yawning may be evidenced more frequently in some in the morning, or alternatively, in the 
evening by other people [13]. Yawning at those times when the individual prefers to be asleep adds 
weight to the function of yawning as an arousal mechanism. 
Gallup [14] is a leading proponent of the thermoregulation hypothesis which argues that yawning 
acts as a compensatory cooling mechanism when other homeostatic mechanisms have failed to respond to 
mild central hyperthermia. With homeostatic temperature control located in the hypothalamus, Gallup and 
Gallup Jr [15] propose that the intrinsic involvement of yawning in thermoregulation means that control 
must also be located in the hypothalamus. Like Corey and colleagues [16], they argue that the mechanism 
by which this occurs is a convective cooling, or radiator effect, whereby deep inhalation of cooled air 
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alters the temperature of the blood in the brain by cooling the arterial blood supply. They further propose 
two other mechanisms of cooling aside from counter-current heat exchange (enhanced cerebral blood 
flow and evaporation of sinus mucosa) [17]. Recent reports show the evidence in favour of the 
thermoregulatory theory to be tenable [18].
The most recent addition to theories of yawning is the Thompson [7] cortisol hypothesis which 
suggests that the incidence and frequency of yawning may be connected with cortisol levels. The 
variation in yawning incidence and cortisol levels in fatigue provides support for a correlation between 
the two as fatigue, which has implicit connections with yawning, has been identified as a consequence of 
hypocortisolism in a recent longitudinal study which accounted for multiple confounding variables [19]. 
Activation of the hypothalamic-pituitary-adrenal (HPA) axis by mental and physical stress is known 
to increase cortisol secretion to facilitate the body’s management of the impact of stress and is cited as 
further support for the Thompson [7] cortisol hypothesis. Thompson and Zisa [6] propose that the stress 
imposed on the body by neurological conditions may impact upon cortisol levels and explain  
the incidence of pathological and excessive yawning during the onset of strokes [20] and acute relapse in 
MS [21]. 
Cortisol and multiple sclerosis 
Increased cortisol levels, and the absence of cytokines, within the cerebrospinal fluid of deceased MS 
patients compared to healthy controls, also provides evidence of characteristic and sustained hyperactivity 
of the HPA axis [22]. As elevations in cortisol could not be attributed to the presence of current 
inflammation, they proposed that it may be part of the body’s defence mechanism against MS and to 
promote recovery or to prevent relapse. However, the authors do not state whether they established 
symptom severity at the time of death, and it seems unlikely that all the participants passed away at times 
of remission or reduced inflammation. Thus, the absence of variations in cytokine levels between MS 
patients and controls appears unusual.  People with MS appear to experience greater fluctuations in their 
plasma cortisol levels [23] and sustained hyperactivity within the HPA axis. 
Insensitivity to glucocorticoids resulting from the excessive production of cortisol may facilitate 
increased inflammation due to an unregulated immune system response to infection relapses in MS 
inflammation [26]. Bergh [25] speculates this may increase autoimmunity which could cause a switch to a 
progressive form of the disease; hence, HPA hyperactivity is not merely an indicator but possibly the 
cause (or a predictor), of the onset of a progressive course of MS.  
Michelson and colleagues [26] and suggest that MS differs from other disorders in which 
hypercortisolism is a symptom, such as Cushing’s syndrome, because of the action of the corticotrophin-
releasing hormone (CRH). This is supported by Erkut and colleagues [27] who found an increase in the 
number of cells that produce CRH whose action, in turn, stimulates production of adreno-corticotropic 
hormone (ACTH). They also found significant increase in arginine vasopressin (AVP) co-expressing 
CRH neurons. Vasopressin is a peptide hormone that controls the re-absorption of molecules in the 
tubules of the kidneys by affecting the tissue's permeability. It also increases peripheral vascular 
resistance, which in turn increases arterial blood pressure. It plays a key role in homeostasis, by the 
regulation of water, glucose, and salts in the blood [28]. As AVP potentiates CRH in its action upon the 
secretion of ACTH, this suggests that CRH neurons are hyperactive in MS.  
Curiously, glycyrrhizic acid, found in liquorice, increases the activity of cortisol on the kidney 
functions [29]. Inhibition of the enzyme 11 -hydroxysteroid dehydrogenase type 2, which normally 
inactivates cortisol in the kidney, results in an increase of cortisol levels. One participant asked to eat 
liquorice after providing a saliva sample, was observed to have an increase in cortisol levels [7].  
Fatigue and cortisol in multiple sclerosis 
Fatigue is not only one of the most frequently reported symptoms of MS but has also been described as 
the most disabling aspect of the condition [29]. Mills and Young’s [30] study reported that fatigue had 
consequences for both physical and cognitive activity causing such symptoms as muscle aches, poor 
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coordination, tremor, inability to sustain attention, and poor memory. MS patients tended to view energy 
as a fixed quota which once used results in fatigue and cannot be restored without rest, which is the 
predominant way in which MS patients attempt to manage fatigue. Just under fifty per cent of the 
respondents to the authors’ survey were in agreement that excessive yawning was a feature of their 
fatigue.
Iriarte, Subira and De Castro [31] propose that fatigue in MS falls into three categories: fatigue at 
rest (asthenia), fatigability, and a generalised worsening of symptoms that can be attributed to other 
mechanisms. Their research identified a correlation between the severity of damage to the pyramidal tract, 
and fatigability as a consequence of exertion, whilst asthenia seems connected to immuno-activation. Of 
the participants with fatigue, had damage to the pyramidal tract; however, this was not predictive, as 51% 
with similar abnormalities reported no fatigue, which reduces the strength of their conclusion. The study 
benefited from a large sample size and appears to be comprehensive in its measurement and analysis of 
immuno-activation and Magnetic Resonance Imaging (MRI) scans.  
Morelli, Ravera and Panfoli [32] suggest that the myelin sheath might itself have a part to play in 
energy during wakefulness. The sheath may act as a proton buffer capacitor as the constituents of myelin 
have been shown to be excellent at retaining energy, thus allowing it to provide energy during waking 
hours. Once this charge has been used, sleep would be induced, and the myelin restored with energy. The 
authors argue that increased sleep during infancy may be indicative of incomplete myelino-genesis which 
makes the myelin slower to accumulate energy.  
Yawning in multiple sclerosis 
Postert and colleagues [21] report on a patient with excessive pathological yawning, four times per 
minute, despite sufficient sleep, as a symptom of MS. An MRI scan showed that the patient had multiple 
demyelinated plaques within the brainstem. After three days of treatment with high dose steroids, 
yawning had completely remitted. However, demyelination of the brainstem is common in MS and so 
cannot be the source of pathological yawning. The authors speculate that inflammation in this area causes 
yawning by irritating the ascending activating reticular system. 
Gallup and Gallup Jr [15] and Gallup and colleagues [33] cite the thermoregulatory dysfunction 
characteristic of MS as evidence for the pathological occurrence in the disorder. Evidence indicates that 
cooling improves and alleviates debilitating symptoms of MS with pre-cooling enabling increased 
participation in activity and exercise [34]. Gallup and Eldakar [35] suggest yawning rates are increased 
with initial rises in temperature, but then diminish as temperature approach or exceed body temperature. 
Gallup and colleagues [36] showed that decreases in ambient temperature (34 to 24 degrees Celsius) do 
not increase yawning frequency. 
In healthy people, frequent and repetitive yawning is most commonly the consequence of sleep debt 
[37, 38]. Romeijn and colleagues [39] report that skin warming induces neuronal firing patterns in the 
brain similar to those occurring in sleep, and also inhibits patterns that indicate wakefulness in the 
hypothalamus. As low skin temperatures are correlated with greater efficiency in tasks and an improved 
ability to resist sleep [40] mild skin warming may therefore promote or induce sleep. The suprachiasmatic 
nucleus may become more sensitive to skin temperature if communication between its neurons is 
impaired, making sleep-wake rhythms more susceptible to the influence of skin temperature.  
This is conceivable in MS as such connections could be damaged by demyelination. However, this 
does not provide unequivocal support for Gallup’s [14] thermoregulatory hypothesis, as yawning in 
response to warming may be a consequence of increased feelings of tiredness in response to the change in 
brain activity, and not a homeostatic need to regulate temperature. 
Pathological yawning in MS may also be the result of impaired hypothalamic function. Using MRI 
investigations, Zellini and colleagues [41] determined that despite similarities in hypothalamic volume in 
comparison with healthy controls, MS patients had longer T1 values, which could be a sign of 
demyelination or axonal damage, and that these values were positively correlated with fatigue. 
Impairment of the hypothalamus could also be the source of other MS symptoms such as sleep 
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disturbance, autonomic and metabolic dysfunctions, sexual disturbances and depression. Therefore, the 
hypothalamus may also be fundamental in thermoregulation as this may be the source of dysfunction. 
Nahab’s [42] neuroimaging research suggests involvement of the ventromedial prefrontal cortex 
(vmPFC) in yawning as this area seems to be activated only by yawns. The vmPFC could be a cortical 
releasing mechanism allowing yawning, when appropriate. Demyelination may prevent normal 
functioning of the vmPFC, thus preventing inhibition of inappropriate yawns and leading to the 
pathological and excessive yawning that has been described in people with MS.  
Cortisol and yawning in multiple sclerosis  
Thompson [2] is the first to propose a connection between yawning and cortisol in humans. The 
Thompson Cortisol Hypothesis suggests the incidence and frequency of yawning may be dependent upon 
fluctuations in cortisol. Animal studies are indicative of a link between yawning and cortisol. Removal of 
rats’ adrenal glands almost completely eliminated yawning [43]. Miller and colleagues [44] also suggests 
a connection between yawning and cortisol in animals. Instead of measuring corticosterone, yawns may 
provide a non-invasive method to qualitatively measure stress. Others measures might include plasma 
CORT which can then potentially be correlated with yawning episodes. Despite the difficulty in relating 
animal research to humans, animal studies may give a preliminary indication of a connection. 
Methods
11 male and 15 female volunteers aged between 18-53 years were recruited from students at 
Bournemouth University using the computerised recruitment system (SONA), and Facebook. All 
participants were properly consented according to code of conduct and research guidelines, and exposed, 
under randomised controlled trials guidelines, to three conditions intended to provoke a yawning response 
– 9 photos of people yawning; boring text about yawning; short 3:02 minutes video of person yawning 
(13 yawns during video clip). Comparisons were made with people exposed to the same conditions but 
who did not yawn.  
Saliva samples were collected at start and again after first yawning response, together with electro-
myographical (EMG) data of the jaw muscles to determine rest (5 minutes prior to yawn at post-session 
analysis) and yawning phases of neural activity. If there was no yawning response, then a second saliva 
sample was taken at the end of the experimental paradigm. A yawning susceptibility scale (questionnaire 
designed for this study), Hospital Anxiety and Depression Scale (HADS) [28, 45],  
General Health Questionnaire GHQ28 [46 - 48], and demographic and health details were also 
collected from each participant.  
To avoid disruption or inhibition of the participant’s performance, the researcher sat just outside the 
experimental booth but in sight of the participant. In this way, the researcher could observe when a yawn 
occurred but did not hinder the participant’s reaction to yawn or hinder concentration on viewing the 
presentation stimuli. Exclusion criteria were: chronic fatigue, diabetes, fibromyalgia, heart condition, high 
blood pressure, hormone replacement therapy, multiple sclerosis, and stroke. (People with multiple 
sclerosis were excluded for this study so that observation of people from a healthy population could be 
studied in terms of cortisol levels). Saliva sample is collected at start and again after yawning response (if 
produced). Electro-myographical data of the jaw muscles was collected via surface-placed electrodes to 
determine rest and yawning phases. Between- and within-subjects comparisons were made using t-tests 
and correlations using the SPSS package [version 19]. This enabled a comparison to be made between 
yawner and non-yawner participants as well as between rest status and yawning episodes. 
Ethics
Bournemouth University Research & Ethics approval granted: BU-PS29/6/12; BU-PS18/10/12; BU-
JC28/1/13; BU-KS6/9/13. Professional code of conduct, confidentiality, and safety issues were addressed 
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and approved in the Ethics submission. Data collected was made anonymous, coded, securely stored and 
all coding linking identification to individual participants was destroyed after completion of the study 
analysis. Protective measures were put in place for collection and analysis of saliva samples and the right 
to withdraw was made clear to all participants. Trials ID: ISRCTN61942768. 
Funding 
This research received funding of £6120 from the host institution, Bournemouth University, United 




Normative data for saliva cortisol is known, and lies within the following ranges: (i) Morning collection is 
3.7 – 9.5 nanograms (one billionth of a gram or 10-9) per millilitre of saliva; (ii) Noon collection is 1.2 – 
3.0 nanograms per millilitre; (iii) Evening collection is 0.6 – 1.9 nanograms per millilitre. 
There were differences between sample 1 (saliva cortisol) and sample 2 (saliva cortisol) for those 
who yawned, and for those who did not yawn, during the experiment (Tables 1 & 2). 
Table 1. Descriptive data for overall group. 
Table 2. Descriptive data for yawners and non-yawners. 
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For the yawners, repeated-measures t-test: t (11) = -3.115, p = 0.010 (Table 3); for the non-yawners, 
repeated-measures t-test: t(14) = -2.658, p = 0.019 (Table 4). 
Table 3. Paired comparisons for yawners. 
Table 4. Paired comparisons for non-yawners. 
Using analysis for repeated measures, there was high significance for the groups overall but non-
significant interaction, F (1, 26) = 1.588  p = 0.219 (Table 5). 
Table 5. Within-subjects effects overall. 
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Electro-myographical data (EMG) was normally distributed: W (7) = 0.877, p = 0.212. Cortisol 
change scores were not normally distributed: W (27) = 0.743, p < 0.000, necessitating the use of 
Spearman’s rho to enable correlation analysis. There was a moderate, though not significant, correlation 
between cortisol change (from sample 1 to 2) and EMG score: rho (7) = 0.440, p = 0.071 (Table 6).  
Table 6. EMG correlations. 
For the yawners, at rest, the EMG range was -15 to 70 millionth of a volt (mean of 29.7) as 
compared with -225 to 175 (mean of 114.1) after yawning. For non-yawners, the range was -4 to 80 
(mean of 25.6) and -12 to 81 (mean of 26.2) after the stimuli presentation. Therefore, the yawners tended 
to show a larger peak following the yawn as compared with after the stimuli presentation for the non-
yawners. Absolute means were also higher for yawners (Tables 7). 
Table 7. EMG data for yawners and non-yawners. 
There was a difference in EMG readings between the yawners and non-yawners, using t-test: t (7) = -
2.959, p = 0.021 (Table 8). Using analysis of variance (ANOVA), there was a difference between 
measures at rest (p = 0.036) and after yawn (or after presentation) (p = 0.006) (Table 9). 
Table 8. Analysis of EMG data. 
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Table 9. Differences between EMG values at rest and second time point 
                             a. R Squared = .023 (Adjusted R Squared = -.016) 
                             b. R Squared = .048 (Adjusted R Squared = .010) 
                             c. R Squared = .133 (Adjusted R Squared = .098) 
                             d. R Squared = .001 (Adjusted R Squared = -.039) 
                             e. R Squared = .164 (Adjusted R Squared = .130) 
                             f.  R Squared = .262 (Adjusted R Squared = .232) 
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Yawning susceptibility scores, W (27) = 0.790, p < 0.000, and cortisol change scores (Tables 3 & 4) 
were not normally distributed. Using Mann-Whitney U test, there were no significant differences between 
yawners and non-yawners: U = 83.5, p = 0.755 (Table 10). 
Table 10. Normality correction. 
Differences between cortisol absolute values for yawners and non-yawners were found (p = 0.002 at 
Table 11; p = 0.034 at Table 12). 
Table 11. Cortisol values between groups – analysis 1. 
Table 12. Cortisol values between groups – analysis 2 
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Using Mixed 2 x 2 ANOVA, for yawners, there was a significant difference between cortisol 
samples, F (1, 11) = 13.680  p < 0.01. To account for multiple comparisons, the cut-off point for 
significance is reduced to p < 0.025. Hence, this result remains significant (Table 13). For non-yawners, 
samples were also different though not significant, F (1, 14) = 4.758  p = 0.047 (Table 13). 
Table 13. Within-subjects effects: comparisons between yawners and non-yawners. 
Power and Effect Size 
Power and effect sizes were computed based on repeated measures t-tests for both the yawning and non-
yawning group. There was a medium effect size for the non-yawners group (r = 0.467) but a low power 
size (0.359). Results were similar for the yawners group: medium effect size (r = 0.440), and a low power 
size (0.331). 
Discussion 
The elevations in cortisol levels following yawning that are found in this study are consistent with 
previous work [7] which tends to lend support towards the Thompson Cortisol Hypothesis [2, 4, 6]. 
However, it is noted that there were also small rises in cortisol levels in the non-yawners which may be 
explained in terms of the experimental procedure. Since two time points of saliva cortisol sampling were 
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taken for both groups, it is possible to note that cortisol levels rose for both groups in the presence of 
yawn-stimuli; however, it is suggested that for the yawners, the cortisol levels did not reach the threshold 
for yawning, hence no yawn is elicited. This presumes that cortisol levels elicit the yawn response. If 
elevated cortisol levels are an artefact of the yawn, then these levels are lower than with the yawners 
because no yawn was elicited.  
In addition, data arising from measuring jaw muscle neural activity has shown significant correlation 
with elevated cortisol levels following the episode of yawning. These data tend to support the notion that 
yawning is not just a mechanism for increasing air to the lungs; rather, it is a complex set of underlying 
sub-mechanisms.  
Indeed, past research has commented on several important roles of neurotransmitters and amino 
acids involved during yawning [1]. It is possible that cortisol plays a much larger role in regulating our 
body’s chemistry than has been previously thought; and the role of heightened electrical activity in 
muscles may also have effects upon body chemistry regulation. Simply put, when we yawn, the neurons 
regulating our jaw muscles are fired and the blood cortisol levels rise (Figure 1). However, it is unclear 
which happens first: perhaps cortisol levels rise during stress, fatigue, or when the brain temperature rises 
dramatically and triggers a yawn response. For non-yawners, although there is also a rise in cortisol, it is 
proposed that the elevation is insufficient to elicit a yawn, if cortisol is trigger. Alternatively, cortisol 
levels are associated with a yawn but rise after a yawn (ie non-elicitatory), then they may be inconsistent 
with the levels associated with a yawn episode.  
Cortisol does seem to act, in many situations, in protection of our body. This is in terms of regulating 
the hormones released within the Hypothalamus-Pituitary-Adrenal axis. A yawn reflex may give rise to 
an increase in cortisol levels in order to afford relief in symptoms of stress; or alternatively, elevated 
cortisol levels are produced by a yawn reflex in order to provide symptom relief. Indeed, Gallup [33] 
reports how multiple sclerosis patients report symptom relief following yawns. It is possible that the 
temperature regulatory function of the hypothalamus is also governed by the levels of cortisol produced 
so as to maintain homeostasis of both temperature and to prevent fatigue as a result of stress. 
Figure 1. Episode of yawning and EMG trace. 
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Like many studies of neurological disorders, there is often a complexity in the interaction of 
neurotransmitters involved, just like that seen in Parkinson’s disease or in the treatment management of 
Alzheimer’s disease [49].    
Age, recent anxiety and depression levels, and general health were measured. These are all potential 
factors that can affect the change data seen in EMG and cortisol levels.  However, on analysis of these 
data, there were no contributory interference effects to change data.  
Close inspection of data suggests that the differences between groups in terms of cortisol change 
between sample one and two is not huge in size. Greater numbers of participants will allow random 
allocation to each group of larger numbers; for example, using G*Power calculation, for a power size of 
0.80, 27 participants will be required for each group (healthy yawners and healthy non-yawners). Aiming 
for 100 participants initially in the healthy group, this should enable random allocation of 50 participants 
per yawners and non-yawners. Additional numbers will be required for neurological groups, yawners and 
non-yawners. 
In terms of EMG data, the range of values after a yawn was higher than that for the non-yawners 
after the stimuli presentation. Absolute means for yawners were higher than for the non-yawners at both 
rest and after the yawn (compared with after the stimuli presentation for non-yawners). It is suggested that 
the threshold for yawn is not reached in the non-yawners and that EMG data reflects the rises in cortisol 
levels at each of these time points. 
The clinical research team led by the first author at Bournemouth University is working towards 
developing a diagnostic tool for the early identification of neurological sequelae. Along the way, this 
scientific pursuit may help shed light on the fascinating and complex entity that is cortisol and help us to 
understand better the ancient phenomenon of the yawning response. 
Conclusions 
Cortisol production appears to have many roles, including protection and regulation of other chemicals. 
Of particular interest is the role of cortisol in neurological disorders such as multiple sclerosis and stroke. 
Yawning seems to be a fundamental mechanism that occurs in all of us, yet malfunction, or increase and 
decrease in frequency may be associated with changes in cortisol levels.
Tapping into this interesting phenomenon has led the clinical research team at Bournemouth 
University, led by the first author, to conclude that cortisol affects yawning in some way. Neural activity 
is also closely associated with rises in cortisol levels during the yawning phase. It is uncertain whether or 
not elevated cortisol levels are an artefact of the yawn or trigger the yawn reflex. There also seems to be a 
threshold at which a yawn is produced and related to the level of cortisol produced. It is possible that the 
temperature regulation of the hypothalamus is also linked with these cortisol elevation in turn regulating 
the production of hormones associated with the Hypothalamus-Pituitary-Adrenal axis feedback 
mechanism. 
These findings are of interest because they have potentially important implications for many 
neurological disorders where there is dysregulation of cortisol or where yawning frequency is altered. 
Diagnosis of neurological disorders is often a complex process with associated timelines. If we are able to 
understand the association of cortisol, neural activity and yawning, then we may have some direction in 
understanding how, and importantly, when neurological disorders are occurring in the individuals who 
present at our clinics. 
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